Antonio Chistolini | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillations: the MAS study	BLOOD ADVANCES	2024
Evaluation of VTE-PREDICT Risk Score in Patients Receiving Low-Dose DOACs for Venous Thromboembolism (VTE) Secondary Prophylaxis	MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES	2024
Secondary Prophylaxis of Venous Thromboembolism (VTE) with Low Dose Apixaban or Rivaroxaban: Results from a Patient Population with More than 2 Years of Median Follow-up	MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES	2024
More early bleeds associated with high baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study	BLOOD ADVANCES	2024
Inappropriate underdosing of direct oral anticoagulants in atrial fibrillation patients. results from the START2-AF registry	JOURNAL OF CLINICAL MEDICINE	2024
Long-term outcomes in two-year follow-up after primary treatment in patients with a prior venous thromboembolic event. a prospective, observational, real-life study	JOURNAL OF CLINICAL MEDICINE	2024
Secondary prophylaxis of venous thromboembolism (VTE) with low dose apixaban or rivaroxaban in major-thrombophilia carriers	ANNALS OF HEMATOLOGY	2024
Venous thromboembolism secondary prophylaxis in elderly people (over 75-year-old) with low-dose direct oral anticoagulants: single-center Italian experience	BLOOD COAGULATION & FIBRINOLYSIS	2024
Fostamatinib combined with TPO‐RAs or steroids as a bridge to monotherapy or as time‐limited continuous treatment in relapsed chronic ITP: A single‐centre case series	BRITISH JOURNAL OF HAEMATOLOGY	2024
Treatment with direct oral anticoagulants (DOACs) and secondary prophylaxis in patients affected by multiple episodes of superficial venous thrombosis	EUROPEAN JOURNAL OF INTERNAL MEDICINE	2024
Increased von Willebrand Factor Platelet-Binding Capacity Is Related to Poor Prognosis in COVID-19 Patients	THROMBOSIS AND HAEMOSTASIS	2023
Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes	RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS	2023
Vaccine-induced immune thrombotic thrombocytopenia: a possible pathogenetic role of ChAdOx1 nCoV-19 vaccine encoded soluble SARS-CoV-2 spike protein	HAEMATOLOGICA	2022
Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants: comparison between patients with major congenital thrombophilia versus non-thrombophilic patients	INTERNAL AND EMERGENCY MEDICINE	2022
Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register	INTERNAL AND EMERGENCY MEDICINE	2022
Thromboembolic events following mRNA vaccines for COVID 19: a case series	JOURNAL OF THROMBOSIS AND THROMBOLYSIS	2022
Immune thrombocytopenia during covid-19 pandemic: An italian monocentric experience	EJHAEM	2022
Cancer-associated venous thromboembolism: the Onco-VTE START2 - Registry	213S2 (2022) S11–S42	2022
Diagnostica di laboratorio e strumentale	Ematologia Smart, Edizioni Idelson Gnocchi 1908	2022
Complicanze in corso di emopatie ed emergenze emorragiche e trombotiche	Ematologia Smart, Edizioni Idelson Gnocchi 1908	2022